Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The French domestic “sanitary pass” did not solve Covid-19 vaccination inequities in France

View ORCID ProfileDébarre Florence, Lecoeur Emmanuel, Guimier Lucie, Jauffret-Roustide Marie, Jannot Anne-Sophie
doi: https://doi.org/10.1101/2022.01.03.22268676
Débarre Florence
1Institute of Ecology and Environmental Sciences of Paris (IEES-Paris, UMR 7618), CNRS, Sorbonne Université, UPEC, IRD, INRAE, 75252 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Débarre Florence
Lecoeur Emmanuel
2Clinical research unit, Hôpital Européen Georges Pompidou, APHP, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guimier Lucie
3French Institute of Geopolitics, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jauffret-Roustide Marie
4Centre d’Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR8044/EHESS), Paris, France
5British Columbia Center For Substance Use (BCCSU), Vancouver, Canada
6Bady Center on Law and Social Policy, Buffalo, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jannot Anne-Sophie
7Medical Informatics, biostatistics and public health unit, Hôpital Européen Georges Pompidou, APHP, Paris, France
8Université de Paris, Paris, France
9HeKA, Centre de Recherche des Cordeliers, Inserm, INRIA, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: annesophie.jannot@aphp.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The French sanitary pass led to an increase in vaccination rates in France, but local heterogeneities in vaccination rates remain. To identify potential determinants of these heterogeneities and how the French sanitary pass influenced them, we used a data-driven approach on exhaustive nationwide data, gathering 181 socio-economic and geographic factors. Our analysis reveals that, both before and after the introduction of the French sanitary pass, factors with the largest impact are related to poverty, with the most deprived areas having greater than 10 times the odds of being among the districts with lower vaccination rates.

Introduction

The rapid development of effective COVID-19 vaccines brought the hope of a rapid return to normalcy, but heterogeneous vaccination rates, both among countries because of inequitable distributions of doses [Usher21] and within countries [Caspi21, Murthy21], jeopardize epidemic control.

Hesitancy and hostility toward vaccination have been comparatively high in France in recent decades [Ward19], a trend confirmed with the COVID-19 pandemic [Lazarus21, Spire21], although acceptance of the COVID-19 vaccine gradually grew during 2021 [SantePubliqueFrance21].

Attitudes toward vaccination are known to be influenced by social and territorial inequalities. Surveys conducted in 2020 in France showed that respondents with lower education [Schwarzinger21, Spire21], lower income levels or less trust in authorities [Spire21] were more likely to be hostile to COVID-19 vaccines. Whether differential intentions translated into effective differences in vaccination, as described in other countries [Caspi21, Murthy21], remained to be shown in France.

To speed up vaccination, President Macron announced on 12 July 2021 the implementation of a domestic “sanitary pass” (le passe sanitaire), which came fully into force on 9 August 2021. It was required in most cultural venues, for both indoor and outdoor dining and in health structures. This announcement led to an unprecedented demand for vaccination, which was celebrated internationally. Vaccination rates climbed from 54% of the whole population by 12 July 2021 to 69% on 4 September 2021. Because it targeted pay-for social activities, however, the “sanitary pass” was feared to have a limited impact on vaccination inequities.

This study aims to obtain further insights into the association between social inequities, vaccination and sanitary pass implementation in France using nationwide data.

Methods

The French state health insurance service (Assurance Maladie) provides public datasets of exhaustive weekly first-dose vaccination data at the district scale nationally and at the suburban scale for the Paris, Lyon, and Marseille metropolitan areas. Our data included 1552 districts in mainland France (63,601,670 individuals; median district size 22,705 inhabitants; interquartile range 6,282--39,128). We associated these data with 176 socioeconomic and 5 geographic indicators at the same geographic scales from public datasets.

We considered the association between being a district in the lowest quartile of the first-dose vaccination rate and being above the median value of each indicator. We computed odds ratios and their 95% confidence intervals at three time points: week 27 (just before the sanitary pass announcement), week 31 (when the sanitary pass came fully into force), and week 35 (end of data collection). For the two indicators achieving the highest odds ratios, we computed vaccination levels for each indicator quartile on the same dates. Analyses were done using R (v4.0.3).

Results

The two indicators most associated with local vaccination rates (figure 1) were the income rate coming from unemployment benefits (w27: OR=12.6 [8.7; 18.9]; w31: OR=13.3 [9.1; 20.0]; w35: OR=11.9 [8.2; 17.6]; the brackets correspond to 95% CI) and the proportion of overcrowded households (w27: OR=11.6 [8,3; 16.4], w31: OR=12.0 [8.6; 17.1], w35: OR=15.7 [11.0; 23.0]).

Figure 1:
  • Download figure
  • Open in new tab
Figure 1:

Odds ratio (OR) and their 95% confidence intervals for the association between vaccination rate and each of the 181 selected indicators at week 27 (panel A), 31 (panel B) and 35 (panel C)

Figure 2:
  • Download figure
  • Open in new tab
Figure 2:

Local vaccination rates depending on the quartile of the two main indicators (Overcrowding rate, left and Unemployment rate, right) and over time (weeks 27, 31, 35, with increasingly darker shading)

The difference in vaccination rates (in percentage points) between the first and fourth quartiles of the two indicators remained similar across weeks (figure S1): unemployment w27: ΔQ1-4= 7.6 [6.6; 8.7], w31: ΔQ1-4= 8.0 [7.0; 9.0], w35: ΔQ1-4= 7.9 [6.9; 8.9], and overcrowding w27: ΔQ1-4= 6.9 [5.7; 8.1], w31: ΔQ1-4= 7.6 [6.6; 8.8], w35: ΔQ1-4= 8.2 [7.2; 9.1].

Discussion

Our results based on exhaustive national datasets indicate that the most deprived areas have greater than 10 times the odds of being among the districts with lower vaccination rates. Lower vaccination rates in France are still associated with poverty, meaning that the sanitary pass did not resolve vaccine inequities. Specifically, living in a district with a large fraction of overcrowded housing or in which unemployment benefits represent a large share of the local income is a strong determinant of a lower COVID-19 vaccination rate in France.

Our study confirms the strong impact of social inequalities on COVID-19. The most deprived areas have already been shown to have been disproportionately infected and hospitalized during the pandemic [Jannot21, Bajos21]. We show that poorer districts are also the least vaccinated and, hence, the most still at risk, despite the widely celebrated domestic sanitary pass. There is an urgent need to define new vaccination policies that truly address social inequities.

Data Availability

This study involves only openly available data: - INSEE: https://www.insee.fr/fr/statistiques/5359146#consulter - Assurance Maladie: https://datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/https://datavaccin-covid.ameli.fr/explore/dataset/donnees-de-vaccination-parcommune/information/

https://www.insee.fr/fr/statistiques/5359146#consulter

https://datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/

https://datavaccin-covid.ameli.fr/explore/dataset/donnees-de-vaccination-parcommune/information/

Acknowledgements

We thank the producers of public datasets, in particular David Levy at INSEE and and Antoine Rachas at Assurance Maladie.

Footnotes

  • Funding EL received funding to match socio-economic data with medical data from AP-HP Centre Université de Paris.

  • Conflict of interest statement No conflict of interest to disclose

  • Data sources INSEE: https://www.insee.fr/fr/statistiques/5359146#consulter

    Assurance Maladie: https://datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/https://datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-parcommune/information/

References

  1. [1].↵
    Bajos, Nathalie, Florence Jusot, Ariane Pailhé, Alexis Spire, Claude Martin, Laurence Meyer, Nathalie Lydié, et al. ‘When Lockdown Policies Amplify Social Inequalities in COVID-19 Infections: Evidence from a Cross-Sectional Population-Based Survey in France’. BMC Public Health 21, no. 1 (December 2021): 705. https://doi.org/10.1186/s12889-021-10521-5.
    OpenUrlPubMed
  2. [2].↵
    Caspi, Gil, Avshalom Dayan, Yael Eshal, Sigal Liverant-Taub, Gilad Twig, Uri Shalit, Yair Lewis, Avi Shina, and Oren Caspi. ‘Socioeconomic Disparities and COVID-19 Vaccination Acceptance: A Nationwide Ecologic Study’. Clinical Microbiology and Infection, June 2021, S1198743X21002779. https://doi.org/10.1016/j.cmi.2021.05.030.
  3. [3].↵
    Jannot, Anne-Sophie, Hector Countouris, Alexis Van Straaten, Anita Burgun, Sandrine Katsahian, and Bastien Rance. ‘Low-Income Neighbourhood Was a Key Determinant of Severe COVID-19 Incidence during the First Wave of the Epidemic in Paris’. Journal of Epidemiology and Community Health, 30 June 2021, jech-2020-216068. https://doi.org/10.1136/jech-2020-216068.
  4. [4].↵
    Lazarus, Jeffrey V., Scott C. Ratzan, Adam Palayew, Lawrence O. Gostin, Heidi J. Larson, Kenneth Rabin, Spencer Kimball, and Ayman El-Mohandes. ‘A Global Survey of Potential Acceptance of a COVID-19 Vaccine’. Nature Medicine 27, no. 2 (February 2021): 225–28. https://doi.org/10.1038/s41591-020-1124-9.
    OpenUrlPubMed
  5. [5].↵
    Murthy, Bhavini Patel, Natalie Sterrett, Daniel Weller, Elizabeth Zell, Laura Reynolds, Robin L. Toblin, Neil Murthy, et al. ‘Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021’. MMWR. Morbidity and Mortality Weekly Report 70, no. 20 (21 May 2021): 759–64. https://doi.org/10.15585/mmwr.mm7020e3.
    OpenUrlCrossRef
  6. [6].↵
    Santé Publique France. ‘CoviPrev : Une Enquête Pour Suivre l’évolution Des Comportements et de La Santé Mentale Pendant l’épidémie de COVID-19’, 2 November 2021. https://www.santepubliquefrance.fr/etudes-et-enquetes/coviprev-une-enquete-pour-suivre-levolution-des-comportements-et-de-la-sante-mentale-pendant-l-epidemie-de-covid-19#block-325952.
  7. [7].↵
    Schwarzinger, Michaël, Verity Watson, Pierre Arwidson, François Alla, and Stéphane Luchini. ‘COVID-19 Vaccine Hesitancy in a Representative Working-Age Population in France: A Survey Experiment Based on Vaccine Characteristics’. The Lancet Public Health 6, no. 4 (April 2021): e210–21. https://doi.org/10.1016/S2468-2667(21)00012-8.
    OpenUrl
  8. [8].↵
    Spire, Alexis, Nathalie Bajos, and Léna Silberzan. ‘Social Inequalities in Hostility toward Vaccination against Covid-19’. Preprint. Public and Global Health, 10 June 2021. https://doi.org/10.1101/2021.06.07.21258461.
  9. [9].↵
    Usher Ann Danaiya. ‘A Beautiful Idea: How COVAX Has Fallen Short’. The Lancet 397, no. 10292 (June 2021): 2322–25. https://doi.org/10.1016/S0140-6736(21)01367-2.
    OpenUrl
  10. [10].↵
    Ward, Jeremy K., Patrick Peretti-Watel, Aurélie Bocquier, Valérie Seror, and Pierre Verger. ‘Vaccine Hesitancy and Coercion: All Eyes on France’. Nature Immunology 20, no. 10 (October 2019): 1257–59. https://doi.org/10.1038/s41590-019-0488-9.
    OpenUrl
Back to top
PreviousNext
Posted January 05, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The French domestic “sanitary pass” did not solve Covid-19 vaccination inequities in France
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The French domestic “sanitary pass” did not solve Covid-19 vaccination inequities in France
Débarre Florence, Lecoeur Emmanuel, Guimier Lucie, Jauffret-Roustide Marie, Jannot Anne-Sophie
medRxiv 2022.01.03.22268676; doi: https://doi.org/10.1101/2022.01.03.22268676
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
The French domestic “sanitary pass” did not solve Covid-19 vaccination inequities in France
Débarre Florence, Lecoeur Emmanuel, Guimier Lucie, Jauffret-Roustide Marie, Jannot Anne-Sophie
medRxiv 2022.01.03.22268676; doi: https://doi.org/10.1101/2022.01.03.22268676

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8790)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (395)
  • Infectious Diseases (except HIV/AIDS) (10567)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1756)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1845)
  • Public and Global Health (3986)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)